Page 119 - TD-4-1

Tumor Discovery HHT inhibits pancreatic cancer progress

heterogeneity: Integrating omics and clinical data. Nat Rev cancer cells. J Cell Biochem. 2018;119(8):6644-6656.
Cancer. 2022;22(3):131-142.
doi: 10.1002/jcb.26847
doi: 10.1038/s41568-021-00418-1
14. Fountzilas G, Lim LO, Yunis AA. The inhibitory effects
4. Christenson ES, Jaffee E, Azad NS. Current and emerging of teniposide and homoharringtonine on the growth
therapies for patients with advanced pancreatic ductal of pancreatic carcinoma cells in vitro. Anticancer Res.
adenocarcinoma: A bright future. Lancet Oncol. 1988;8(3):343-346.
2020;21(3):e135-e145.
15. Sarwar A, Zhu Z, Zhu M, et al. Homoharringtonine
doi: 10.1016/S1470-2045(19)30795-8 sensitizes pancreatic cancer to erlotinib by direct targeting
5. Niu N, Shen X, Wang Z, et al. Tumor cell-intrinsic epigenetic and miRNA-130b-3p-mediated EphB4-JAK2-STAT3 axis.
dysregulation shapes cancer-associated fibroblasts J Pharm Pharmacol. 2023;75(10):1294-1309.
heterogeneity to metabolically support pancreatic cancer. doi: 10.1093/jpp/rgad055
Cancer Cell. 2024;42(5):869-884.e9.
16. Han H, Zhao C, Liu M, et al. Mitochondrial complex I
doi: 10.1016/j.ccell.2024.03.005 inhibition by homoharringtonine: A novel strategy
6. Raghavan S, Winter PS, Navia AW, et al. Microenvironment for suppression of chronic myeloid leukemia. Biochem
drives cell state, plasticity, and drug response in pancreatic Pharmacol. 2023;218:115875.
cancer. Cell. 2021;184(25):6119-6137.e26. doi: 10.1016/j.bcp.2023.115875
doi: 10.1016/j.cell.2021.11.017 17. Jeong KY, Sim JJ, Park M, Kim HM. Accumulation of poly
7. Li E, Cheung HCZ, Ma S. CTHRC1 fibroblasts and (adenosine diphosphate-ribose) by sustained supply of
+
SPP1 macrophages synergistically contribute to pro- calcium inducing mitochondrial stress in pancreatic cancer
+
tumorigenic tumor microenvironment in pancreatic ductal cells. World J Gastroenterol. 2022;28(27):3422-3434.
adenocarcinoma. Sci Rep. 2024;14(1):17412. doi: 10.3748/wjg.v28.i27.3422
doi: 10.1038/s41598-024-68109-z 18. Zhu X, Zhang Y, Wang Y, et al. Agrimoniin sensitizes
8. Spratlin J, Sangha R, Glubrecht D, et al. The absence of pancreatic cancer to apoptosis through ROS-mediated
human equilibrative nucleoside transporter 1 is associated energy metabolism dysfunction. Phytomedicine.
with reduced survival in patients with gemcitabine- 2022;96:153807.
treated pancreas adenocarcinoma. Clin Cancer Res. doi: 10.1016/j.phymed.2021.153807
2004;10(20):6956-6961.
19. Xia S, Miao Y, Liu S. Withaferin A induces apoptosis by
doi: 10.1158/1078-0432.CCR-04-0224 ROS-dependent mitochondrial dysfunction in human
9. Fresno M, Jiménez A, Vázquez D. Inhibition of translation colorectal cancer cells. Biochem Biophys Res Commun.
in eukaryotic systems by harringtonine. Eur J Biochem. 2018;503(4):2363-2369.
1977;72(2):323-330. doi: 10.1016/j.bbrc.2018.06.162
doi: 10.1111/j.1432-1033.1977.tb11256.x 20. Percie du Sert N, Ahluwalia A, Alam S, et al. Reporting
10. Baaske DM, Heinstein P. Cytotoxicity and cell cycle animal research: Explanation and elaboration for the
specificity of homoharringtonine. Antimicrob Agents ARRIVE guidelines 2.0. PLoS Biol. 2020;18(7):e3000411.
Chemother. 1977;12(2):298-300. doi: 10.1371/journal.pbio.3000411
doi: 10.1128/AAC.12.2.298 21. Marchetti P, Fovez Q, Germain N, Khamari R, Kluza J.

11. Kantarjian HM, O’Brien S, Cortes J. Homoharringtonine/ Mitochondrial spare respiratory capacity: Mechanisms,
omacetaxine mepesuccinate: The long and winding road regulation, and significance in non-transformed and cancer
to food and drug administration approval. Clin Lymphoma cells. FASEB J. 2020;34(10):13106-13124.
Myeloma Leuk. 2013;13(5):530-533. doi: 10.1096/fj.202000767R
doi: 10.1016/j.clml.2013.03.017 22. Fiorini C, Cordani M, Padroni C, Blandino G, Di Agostino S,
12. Powell RG, Weisleder D, Smith CR, Rohwedder WK. Donadelli M. Mutant p53 stimulates chemoresistance of
Structures of harringtonine, isoharringtonine, and pancreatic adenocarcinoma cells to gemcitabine. Biochim
homoharringtonine. Tetrahedron Lett. 1970;(11):815-818. Biophys Acta. 2015;1853(1):89-100.
doi: 10.1016/s0040-4039(01)97839-6 doi: 10.1016/j.bbamcr.2014.10.003
13. Wang L, Zhao L, Wei G, et al. Homoharringtonine could 23. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB,
induce quick protein synthesis of PSMD11 through Fleshman JM, Matrisian LM. Projecting cancer incidence
activating MEK1/ERK1/2 signaling pathway in pancreatic and deaths to 2030: The unexpected burden of thyroid,

Volume 4 Issue 1 (2025) 111 doi: 10.36922/td.7825